Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?

Aisen PS, Vellas B.

J Nutr Health Aging. 2013 Jan;17(1):49-50. doi: 10.1007/s12603-013-0001-3. No abstract available.

PMID:
23299379
2.

Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.

Schenk D.

Nat Rev Neurosci. 2002 Oct;3(10):824-8. Review. No abstract available.

PMID:
12360327
3.

A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.

Lathuilière A, Laversenne V, Astolfo A, Kopetzki E, Jacobsen H, Stampanoni M, Bohrmann B, Schneider BL, Aebischer P.

Brain. 2016 May;139(Pt 5):1587-604. doi: 10.1093/brain/aww036. Epub 2016 Mar 8.

PMID:
26956423
4.

Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.

Lee EB, Leng LZ, Lee VM, Trojanowski JQ.

FEBS Lett. 2005 May 9;579(12):2564-8. Epub 2005 Apr 7.

5.

Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

Li Y, Liu Y, Wang Z, Jiang Y.

Expert Opin Biol Ther. 2013 Nov;13(11):1515-22. doi: 10.1517/14712598.2013.838555. Epub 2013 Sep 22. Review.

PMID:
24053611
6.

Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.

Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, Takahashi H, Fukumoto H, Horiguchi T, Suzuki N, Shoji M.

Neurodegener Dis. 2005;2(1):36-43.

PMID:
16909001
7.

Novel approaches for immunotherapeutic intervention in Alzheimer's disease.

Vasilevko V, Cribbs DH.

Neurochem Int. 2006 Jul;49(2):113-26. Epub 2006 Jun 12. Review.

PMID:
16765487
8.

Vaccine for Alzheimer's disease?

[No authors listed]

Health News. 2006 Oct;12(10):2. No abstract available.

PMID:
17162790
9.

Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.

Chauhan NB, Siegel GJ.

Expert Rev Vaccines. 2004 Dec;3(6):717-25. Review.

PMID:
15606357
10.

Immunotherapy for Alzheimer's disease.

Morgan D.

J Intern Med. 2011 Jan;269(1):54-63. doi: 10.1111/j.1365-2796.2010.02315.x. Review.

11.

Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy.

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Tortelli R, Galizia I, Prete C, Daniele A, Pilotto A, Greco A, Logroscino G.

Immunotherapy. 2016 Sep;8(9):1119-34. doi: 10.2217/imt-2016-0019.

PMID:
27485083
12.

Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.

Frost JL, Liu B, Kleinschmidt M, Schilling S, Demuth HU, Lemere CA.

Neurodegener Dis. 2012;10(1-4):265-70. doi: 10.1159/000335913. Epub 2012 Feb 16.

13.

Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.

Chauhan NB, Siegel GJ.

J Neurosci Res. 2003 Oct 1;74(1):142-7.

PMID:
13130516
14.

Is passive immunization for Alzheimer's disease 'alive and well' or 'dead and buried'?

Jicha GA.

Expert Opin Biol Ther. 2009 Apr;9(4):481-91. doi: 10.1517/14712590902828285 . Review.

15.

Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.

Cribbs DH.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):207-16. Review.

16.

Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.

Schiltz JG, Salzer U, Mohajeri MH, Franke D, Heinrich J, Pavlovic J, Wollmer MA, Nitsch RM, Moelling K.

J Mol Med (Berl). 2004 Oct;82(10):706-14.

PMID:
15241501
17.

Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.

Rygiel K.

Indian J Pharmacol. 2016 Nov-Dec;48(6):629-636. doi: 10.4103/0253-7613.194867. Review.

18.

Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.

Geylis V, Steinitz M.

Autoimmun Rev. 2006 Jan;5(1):33-9. Epub 2005 Aug 1. Review.

PMID:
16338209
19.

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.

Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS.

J Neuroinflammation. 2010 Sep 28;7:57. doi: 10.1186/1742-2094-7-57.

20.

Testing the amyloid hypothesis of Alzheimer's disease in vivo.

Gandy S.

Lancet Neurol. 2010 Apr;9(4):333-5. doi: 10.1016/S1474-4422(10)70055-7. Epub 2010 Feb 26. No abstract available.

Supplemental Content

Support Center